Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Debt to Assets Over TimeElevated
Percentile Rank100
3Y CAGR+0.6%
5Y CAGR+28.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
+0.6%/yr
Annual compound
5Y CAGR
+28.7%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
3.5x
Strong expansion
Streak
1 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.10 | +21.7% |
| 2023 | 0.08 | -4.8% |
| 2022 | 0.09 | -12.1% |
| 2021 | 0.10 | +1678.7% |
| 2020 | 0.01 | -80.5% |
| 2019 | 0.03 | - |
| 2018 | 0.00 | - |